Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Super funds back COVID-19 preventative drug

Four major superannuation funds are backing a biotech company that is developing a nasal spray that claims to prevent COVID-19 and the common cold.

Upgrade your subscription to access this article

And gain access to:
  • All archived news content
  • Access to the Financial Standard app
  • Home page news customisation
  • Financial Standard 's fortnightly newspaper
  • 25% discount on tickets to networking events
And more
Already A Subscriber?

Read more: Ena RespiratoryAustralianSuperBrandon CapitalChristophe DemaisonCSLHESTAHostplusStatewide Super